Pular para o conteúdo
Merck
Todas as fotos(1)

Documentos Principais

Visualizar Toda a Documentação

Y0001409

Testosterone propionate for system suitability

European Pharmacopoeia (EP) Reference Standard

Sinônimo(s):

Testosterone propionate, 17β-Hydroxy-4-androsten-3-one 17-propionate, 17β-Propionyloxy-4-androsten-3-one, 4-Androsten-17β-ol-3-one 17-propionate

Faça loginpara ver os preços organizacionais e de contrato
Todas as fotos(1)

About This Item

Fórmula empírica (Notação de Hill):
C22H32O3
Número CAS:
57-85-2
Peso molecular:
344.49
Beilstein:
3221760
Número MDL:
MFCD00003653
Código UNSPSC:
41116107
ID de substância PubChem:
329831409
NACRES:
NA.24

grau

pharmaceutical primary standard

família API

testosterone

fabricante/nome comercial

EDQM

controle de medicamentos

regulated under CDSA - not available from Sigma-Aldrich Canada

aplicação(ões)

pharmaceutical (small molecule)

Formato

neat

temperatura de armazenamento

2-8°C

cadeia de caracteres SMILES

[H][C@@]12CCC3=CC(=O)CC[C@]3(C)[C@@]1([H])CC[C@]4(C)[C@H](CC[C@@]24[H])OC(=O)CC

InChI

1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1

chave InChI

PDMMFKSKQVNJMI-BLQWBTBKSA-N

Informações sobre genes

human ... AR(367)

Procurando produtos similares? Visita Guia de comparação de produtos

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

Testosterone propionate for system suitability EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Embalagem

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Outras notas

Sales restrictions may apply.

produto relacionado

Nº do produto
Descrição
Preços

T0100000

Testosterone, European Pharmacopoeia (EP) Reference Standard

T0240000

Testosterone decanoate, European Pharmacopoeia (EP) Reference Standard

T0250000

Testosterone enantate, European Pharmacopoeia (EP) Reference Standard

T0300000

Testosterone propionate, European Pharmacopoeia (EP) Reference Standard

T0210000

Testosterone caproate, European Pharmacopoeia (EP) Reference Standard

T0260000

Testosterone isocaproate, European Pharmacopoeia (EP) Reference Standard

Y0000696

Testosterone decanoate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0000716

Testosterone isocaproate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001312

Testosterone enantate for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0001317

Testosterone enantate for system suitability, European Pharmacopoeia (EP) Reference Standard

Y0001313

Testosterone enantate impurity H, European Pharmacopoeia (EP) Reference Standard

1649007

Testosterone propionate, United States Pharmacopeia (USP) Reference Standard

1647001

Testosterone cypionate, United States Pharmacopeia (USP) Reference Standard

1648004

Testosterone enanthate, United States Pharmacopeia (USP) Reference Standard

1646031

Testosterone Related Compound C, United States Pharmacopeia (USP) Reference Standard

1646097

Testosterone Related Compound I, United States Pharmacopeia (USP) Reference Standard

BP702

Testosterone propionate, British Pharmacopoeia (BP) Reference Standard

1646010

Testosterone Related Compound A CIII, United States Pharmacopeia (USP) Reference Standard

BP319

Testosterone decanoate, British Pharmacopoeia (BP) Reference Standard

BP321

Testosterone isocaproate, British Pharmacopoeia (BP) Reference Standard

BP1076

Testosterone, British Pharmacopoeia (BP) Reference Standard

1647012

Testosterone Cypionate Related Compound A, United States Pharmacopeia (USP) Reference Standard

PHR2026

Testosterone Propionate, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2027

Testosterone, Pharmaceutical Secondary Standard; Certified Reference Material

1647023

Testosterone Cypionate Related Compound B, United States Pharmacopeia (USP) Reference Standard

Y0002163

Testosterone for ID and assay, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002174

Testosterone for system suitability A, CRS, European Pharmacopoeia (EP) Reference Standard

Y0002145

Testosterone impurity I, CRS, European Pharmacopoeia (EP) Reference Standard

PHR9196

5α-Androstan-17β-ol-3-one, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

Palavra indicadora

Danger

Frases de perigo

H302,H351,H360FD,H400

Classificações de perigo

Acute Tox. 4 Oral - Aquatic Acute 1 - Carc. 2 - Repr. 1A

Código de classe de armazenamento

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

Classe de risco de água (WGK)

WGK 3

Escolha uma das versões mais recentes:

Certificados de análise (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Se precisar de ajuda, entre em contato Atendimento ao cliente

Já possui este produto?

Encontre a documentação dos produtos que você adquiriu recentemente na biblioteca de documentos.

Visite a Biblioteca de Documentos

Kyung Pyo Kang et al.
Molecular medicine reports, 9(6), 2061-2068 (2014-04-01)
Inflammation is a key mediator of renal ischemia-reperfusion (IR) injury. Gender disparities have been reported in acute and chronic kidney disease. In particular, males are considered to be more susceptible to renal ischemic injury compared with females according to animal
A B Firdous et al.
Food & function, 5(10), 2632-2645 (2014-08-29)
Prostate cancer incidence and mortality rates have increased over the past years. The purpose of the present study was to examine the molecular mechanism underlying the chemopreventive effects of quercetin on prostate cancer in an in vivo model. Sprague-Dawley male
Lei Wan et al.
Cancer prevention research (Philadelphia, Pa.), 7(12), 1228-1239 (2014-10-16)
Consumption of tomato products containing the carotenoid lycopene is associated with a reduced risk of prostate cancer. To identify gene expression patterns associated with early testosterone-driven prostate carcinogenesis, which are impacted by dietary tomato and lycopene, wild-type (WT) and transgenic
Negar M Ghahramani et al.
Biology of sex differences, 5, 8-8 (2014-07-01)
The biological basis for sex differences in brain function and disease susceptibility is poorly understood. Examining the role of gonadal hormones in brain sexual differentiation may provide important information about sex differences in neural health and development. Permanent masculinization of
E M Beckett et al.
Reproduction (Cambridge, England), 148(2), 199-209 (2014-05-21)
Gestational testosterone treatment causes maternal hyperinsulinemia, intrauterine growth retardation (IUGR), low birth weight, and adult reproductive and metabolic dysfunctions. Sheep models of IUGR demonstrate placental insufficiency as an underlying cause of IUGR. Placental compromise is probably the cause of fetal
Exibir todos os documentos relacionados

Nossa equipe de cientistas tem experiência em todas as áreas de pesquisa, incluindo Life Sciences, ciência de materiais, síntese química, cromatografia, química analítica e muitas outras.

Entre em contato com a assistência técnica